Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors

Affiliations

• ¹ Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota, 2231 6th St SE, Minneapolis, MN, 55455, USA.
• ² University of Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.
• ³ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
• ⁴ Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota, 2231 6th St SE, Minneapolis, MN, 55455, USA. schwe251@umn.edu.
• ⁵ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. schwe251@umn.edu.
• ⁶ Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. schwe251@umn.edu.
• ⁷ Center for Immunology, University of Minnesota, Minneapolis, MN, USA. schwe251@umn.edu.